Related references
Note: Only part of the references are listed.Trace amine associated receptor 1 (TAAR1) modulators: a patent review (2010-present)
Michele Tonelli et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2020)
A Non-D2-Receptor-Binding Drug for the Treatment of Schizophrenia
Kenneth S. Koblan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Chemistry for Positron Emission Tomography: Recent Advances in 11C-, 18F-, 13N-, and 15O-Labeling Reactions
Xiaoyun Deng et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Trace Amine-Associated Receptor 1 Agonist Modulates Mismatch Negativity-Like Responses in Mice
Aleksander A. Aleksandrov et al.
FRONTIERS IN PHARMACOLOGY (2019)
The Blood-Brain Barrier (BBB) Score
Mayuri Gupta et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases
Michael D. Schwartz et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
Trace Amines and Their Receptors
Raul R. Gainetdinov et al.
PHARMACOLOGICAL REVIEWS (2018)
The Case for TAAR1 as a Modulator of Central Nervous System Function
Grazia Rutigliano et al.
FRONTIERS IN PHARMACOLOGY (2018)
Targeting species-specific trace amine-associated receptor 1 ligands: to date perspective of the rational drug design process
Elena Cichero et al.
FUTURE MEDICINAL CHEMISTRY (2017)
Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges
Mark D. Berry et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Advantages in functional imaging of the brain
Walter Mier et al.
FRONTIERS IN HUMAN NEUROSCIENCE (2015)
Modulation by Trace Amine-Associated Receptor 1 of Experimental Parkinsonism, L-DOPA Responsivity, and Glutamatergic Neurotransmission
Alexandra Alvarsson et al.
JOURNAL OF NEUROSCIENCE (2015)
Development of 18F-labeled radiotracers for neuroreceptor imaging with positron emission tomography
Peter Brust et al.
NEUROSCIENCE BULLETIN (2014)
Positron Emission Tomography (PET) in Oncology
Andrea Gallamini et al.
CANCERS (2014)
Selective antagonists of mouse trace amine-associated receptor 1 (mTAAR1): Discovery of EPPTB (RO5212773)
Henri Stalder et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties
Travis T. Wager et al.
ACS CHEMICAL NEUROSCIENCE (2010)
The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system
Amyaouch Bradaia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Trace amine-associated receptors and their ligands
R. Zucchi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Share Paper
